Physician profile
Jeffrey D Crawford
NPI 1003106071
$45,946.29
in general payments reported to CMS, 2019-2025
28 companies · $4,365 in 2025
The $4,365 reported for 2025 was more than what 83% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,332 · 2020: $1,058 · 2021: $2,374 · 2022: $14K · 2023: $3,501 · 2024: $17K · 2025: $4,365.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Food and Beverage: $7,037 · Travel and Lodging: $5,496 · Consulting Fee: $800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,710.00 |
| Food and Beverage | $7,037.00 |
| Travel and Lodging | $5,496.42 |
| Consulting Fee | $800.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $12,109.09 | 2021-2025 | Endurant Iis, Ellipsys Vascular Access System, Venaseal |
| Penumbra, INC. | $8,750.85 | 2019-2024 | Indigo System, Penumbra System, Ruby Coil |
| Wilson Cook Medical Incorporated | $7,500.00 | 2024 | Zilver Ptx |
| Cook Incorporated | $4,193.46 | 2024 | Zilver Ptx |
| W. L. Gore & Associates, INC. | $3,564.65 | 2021-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Excluder Aaa Endoprosthesis, Product In Development |
| Cagent Vascular INC | $2,982.09 | 2025 | Serrantor |
| Cook Medical LLC | $2,159.49 | 2019-2025 | Zenith Spiral-Z, Cook, Zilver Ptx |
| Medtronic Vascular, INC. | $1,033.30 | 2019-2020 | |
| Shockwave Medical, INC | $596.21 | 2022-2025 | Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave E8 Peripher, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Silk Road Medical, INC. | $574.25 | 2020-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Bard Peripheral Vascular, INC. | $471.19 | 2019-2023 | Venovo |
| Bolton Medical INC | $408.68 | 2019-2025 | Relay Thoracic Stent-Graft With Plus Delivery System, Treo Abdominal Stent-Graft System |
| Cvrx, INC. | $369.12 | 2023-2025 | Barostim Neo System |
| Alphatec Spine, INC | $286.30 | 2023-2024 | Solus Alif |
| Stryker Corporation | $254.40 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Artix Mt |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cordis US Corp. | $158.61 | 2021 | |
| Angiodynamics, INC. | $124.34 | 2022 | |
| Inari Medical, INC. | $79.65 | 2020-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abbott Laboratories | $67.04 | 2024-2025 | Armada, Perclose Prostyle, Esprit |
| Cardinal Health 200 LLC | $49.05 | 2019-2021 | |
| Baxter Healthcare | $40.43 | 2022-2023 | Preveleak |
| Globus Medical, INC. | $36.20 | 2025 | Hedron |
| Becton, Dickinson and Company | $29.52 | 2025 | Rotarexs 6 F X 135 Cm |
| Boston Scientific Corporation | $29.40 | 2025 | Enroute Transcarotid Stent |
| Terumo Medical Corporation | $22.17 | 2025 | Metacross Otw |
| Cardiva Medical, INC. | $21.29 | 2024 | Cardiva Vascade 6/7f Vcs |
| Lemaitre Vascular, INC. | $21.15 | 2022 | |
| Solventum Corporation | $14.36 | 2024 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Crawford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.